Skip to main content
Article thumbnail
Location of Repository

Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients

By Takahiko Nagamine
Topics: Letters
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1999). 0.05 compared with risperidone. Neuropsychiatric Disease and Treatment 2007:3(1) 179 Risperidone and olanzapine in Japanese schizophrenic patients Kugiyama
  2. (1999). Association of plasma triglyceride-rich lipoprotein remnants with coronary artherosclerosis in cases of sudden cardiac death.
  3. (2004). Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro.
  4. (2006). Development of cookie test for the simultaneous determination of glucoseintolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia.
  5. (1999). Different infl uences of classical antipsychotics and clozapine of glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
  6. (2000). Elevated levels of insulin, leptine, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.
  7. (2005). Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents.
  8. (1999). Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care,
  9. (2005). Metabolic syndrome—defi nition and diagnostic criteria in Japan.
  10. (1996). Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apoB100 and apoA-I.
  11. (2004). Uncoupling protein 2 promoter polymorphism—866G/A affects its expression in beta-cells and modulates clinical profi les of Japanese type 2 diabetic patients.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.